Vet-Stem Offers New Adult Stem Cell Culturing Process
Vet-Stem, the highly successful U.S. veterinary adult stem cell company, now offers a service which allows for an "everlasting" supply of adult stem cells.
Vet-Stem, the highly successful U.S. veterinary adult stem cell company, now offers a service which allows for an "everlasting" supply of adult stem cells.
Scientists in Germany have simplified the iPS (induced pluripotent stem) cell reprogramming procedure from four genes to one gene, though the choice of cell type plays an important role.
At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.
Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.
Russia’s Human Stem Cell Institute has announced that it is seeking funding from investors in what promises to be Russia’s first initial public offering in over a year.
Prosecutors in South Korea have recommended a four-year prison term for Hwang Woo-suk, whose fraudulent stem cell reports caused an international scandal.